Amgen Inc.
Cash Flow Statement
| Line Item | FY2009 | FY2008 | FY2007 |
|---|---|---|---|
| Operating Activities | |||
| Net Income | $4.61B | $4.05B | $3.08B |
| Depreciation & Amortization | $1.05B | $1.07B | $1.20B |
| Depreciation | $624.0M | $648.0M | — |
| Amortization | $425.0M | $425.0M | — |
| Stock-Based Compensation | $284.0M | $262.0M | $263.0M |
| Net Cash from Operating Activities | $6.34B | $5.99B | $5.40B |
| Investing Activities | |||
| Capital Expenditures | $530.0M | $672.0M | $1.27B |
| Business Acquisitions | $0 | $56.0M | $697.0M |
| Net Cash from Investing Activities | $-3.20B | $-3.17B | $-1.99B |
| Financing Activities | |||
| Dividends Paid | $0 | — | — |
| Stock Repurchases | $3.21B | $2.27B | $5.10B |
| Net Cash from Financing Activities | $-2.02B | $-3.07B | $-2.67B |
| Net Change in Cash | $1.11B | $-250.0M | $741.0M |
| Free Cash Flow | $5.81B | $5.32B | $4.13B |